Cargando…
Reply to “Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium”
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181745/ https://www.ncbi.nlm.nih.gov/pubmed/34112485 http://dx.doi.org/10.1016/j.jaip.2021.03.031 |
_version_ | 1783704119752523776 |
---|---|
author | Ballow, Mark Haga, Christopher L. |
author_facet | Ballow, Mark Haga, Christopher L. |
author_sort | Ballow, Mark |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8181745 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Academy of Allergy, Asthma & Immunology |
record_format | MEDLINE/PubMed |
spelling | pubmed-81817452021-06-07 Reply to “Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium” Ballow, Mark Haga, Christopher L. J Allergy Clin Immunol Pract Correspondence and Reply American Academy of Allergy, Asthma & Immunology 2021-06 2021-06-07 /pmc/articles/PMC8181745/ /pubmed/34112485 http://dx.doi.org/10.1016/j.jaip.2021.03.031 Text en © 2021 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Correspondence and Reply Ballow, Mark Haga, Christopher L. Reply to “Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium” |
title | Reply to “Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium” |
title_full | Reply to “Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium” |
title_fullStr | Reply to “Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium” |
title_full_unstemmed | Reply to “Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium” |
title_short | Reply to “Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium” |
title_sort | reply to “patient variability in severity of covid-19 disease. main suspect: vascular endothelium” |
topic | Correspondence and Reply |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181745/ https://www.ncbi.nlm.nih.gov/pubmed/34112485 http://dx.doi.org/10.1016/j.jaip.2021.03.031 |
work_keys_str_mv | AT ballowmark replytopatientvariabilityinseverityofcovid19diseasemainsuspectvascularendothelium AT hagachristopherl replytopatientvariabilityinseverityofcovid19diseasemainsuspectvascularendothelium |